Morgan Lewis

Related Publications

04/29/14 FDA Rule Prohibits Certain Nutrient Content Claims for Omega-3 Fatty Acids
The final rule prohibits label claims of food products, including dietary supplements, that are “high in,” “rich in,” or an “excellent source of” DHA or EPA and allows some nutrient content claims for ALA.
04/25/14 FDA Proposes Tobacco Products Rule; E-Cigarettes, Cigars To Be Regulated
The rule would ban the sale of e-cigarettes, cigars, pipe tobacco, and other products to those under 18; would require warning statements on product packages and in advertisements; and would require manufacturers to register and list products the with Agency and submit new products for premarket review.
03/12/14 Medical Device Update: FDA Releases Final Pre-Submission Guidance
The new guidance includes requirements on the type, timing, format, and content of requests for feedback meetings and telephone conferences with FDA. Therefore, it will be important for the medical device industry to be aware of these requirements in planning their device development activities and timelines.
View all publications

Related News

10/24/12 CLS Negotiates Opportunity for Medicaid Reinstatement
Morgan Lewis partnered with Community Legal Services of Philadelphia to find an agreeable solution to increase enrollment and restore Medicaid coverage for children and families in the city.
View all news
Photo of  Jonathan A. Havens

practice accolades

FDA

Named the Healthcare Pricing and Reimbursement Firm of the Year by LMG Life Sciences (2013)

Ranked the second-largest U.S. healthcare law firm by Modern Healthcare (2012–2013)

Recognized as a top 10 law firm within the Life Sciences Regulatory Super League by The Practical Law Company (PLC) (2012)

Listed as Recommended in PLC's Life Sciences Multi-Jurisdictional Guide (2012)

honors + affiliations

Recipient, FDA Group Recognition Award

Recipient, FDA Center for Tobacco Products Team Excellence Award

Member, Health Law Section, American Bar Association

Member, American Health Lawyers Association

Member, Food and Drug Law Institute

bar admissions

  • District of Columbia
  • Virginia
  • Florida
print profile

Jonathan A. Havens
Associate


Email: jhavens@morganlewis.com
Washington, D.C.
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
United States of America
Phone: +1.202.739.5952
Fax: +1.202.739.3001

Jonathan A. Havens is an associate in Morgan Lewis's FDA Practice. His practice focuses on FDA and healthcare regulatory, compliance, enforcement, and transactional issues. In this capacity, Mr. Havens represents clients in matters relating to medical devices, prescription and non-prescription pharmaceuticals, foods, food additives, dietary supplements, and cosmetics, as well as marketing, promotion, and advertisement. He assists clients in various matters related to state regulatory requirements, including state licensing requirements, for healthcare providers and pharmacies, as well as drug and device manufacturers and distributors. 

Mr. Havens advises clients on regulatory and compliance matters of the Consumer Product Safety Commission, the Drug Enforcement Administration, the Department of Veterans Affairs, the Small Business Administration, and Customs and Border Protection. His experience includes representing clients before the Food and Drug Administration, the Department of Health and Human Services, and the Consumer Product Safety Commission.

Prior to joining Morgan Lewis, Mr. Havens was a regulatory counsel with the U.S. Food and Drug Administration. While at the FDA, Mr. Havens received an FDA Group Recognition Award for Compliance and Enforcement of Tobacco Product Regulations and a Center for Tobacco Products Team Excellence Award. Before his legal career, Mr. Havens was a legislative aide in the U.S. Senate and U.S. House of Representatives, as well as a legislative specialist with a national law firm.

Mr. Havens's recent representative client matters include:

  • Represented a multinational pharmaceutical company in its successful request for orphan drug designation
  • Represented a medical device company in a pair of successful applications for marketing clearance
  • Represented a mail order pharmacy in its sale of stock to a pair of private equity groups

Mr. Havens maintains an active pro bono practice, and has represented clients before the D.C. Superior Court, the Social Security Administration, and the Centers for Medicare and Medicaid Services and related state agencies.

Beyond his representational experience, Mr. Havens has written and spoken about federal and state health industry transparency requirements, and he is member of the Morgan Lewis Health Industry Transparency Compliance Team. He has also written about pharmacy billing practices and food safety.

Mr. Havens earned his J.D. from the Catholic University of America, Columbus School of Law in 2010, where he was an associate editor for the Catholic University Law Review. He earned his B.A. in American politics from the University of Virginia in 2005, where he graduated on the Dean's List.

Mr. Havens is admitted to practice in the District of Columbia, Virginia, and Florida.

education

  • Catholic University of America, Columbus School of Law, 2010, J.D.
  • University of Virginia, 2005, B.A.